SQUAMOUS-CELL NON-SMALL CELL LUNG CANCER
Clinical trials for SQUAMOUS-CELL NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS-CELL NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS-CELL NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters human testing for Tough-to-Treat cancers
Disease control Recruiting nowThis is the first study in people testing an experimental drug called ABBV-324 for advanced liver cancer or a type of lung cancer. The main goals are to find a safe dose, see how the body processes the drug, and check if it helps shrink tumors. The study will enroll about 232 adu…
Matched conditions: SQUAMOUS-CELL NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New Two-Pronged cancer drug enters human trials
Disease control Recruiting nowThis study is testing a new, experimental drug called GI-101 in people with advanced cancers that have spread. The main goals are to find a safe dose and see if the drug, given alone or with other approved cancer medicines, can help shrink tumors. The trial will enroll about 317 …
Matched conditions: SQUAMOUS-CELL NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC